The Nobel for Teaching Chemistry to Pick a Hand

Your proteins are built from left-handed amino acids. The sugars in your DNA are right-handed. Each of those molecules has a mirror twin with the same atoms in the same order, and life almost never uses it. For more than a century, nobody could show how chemistry, left to itself, might end up choosing one side.

On October 7, the Royal Swedish Academy of Sciences gave the 2026 Nobel Prize in Chemistry to Henri B. Kagan of the then Université Paris-Sud and Kenso Soai of Tokyo University of Science "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis." Heiner Linke, who chairs the Nobel Committee for Chemistry, called it "a solution to a chemical mystery that is over a century old: how homochirality can emerge spontaneously."

The prize honours two things at once: a tool that drug chemists rely on, and an experiment that comes closer than anything else to how life's one-handedness could have started.

Why handedness is a drug problem

Molecules that exist as mirror pairs are called chiral, and the two versions are enantiomers. In a flask, a reaction that can make both usually makes equal amounts of each. In a body, the two can behave very differently. The Nobel committee's popular background uses carvone as the gentle example: one form smells of mint, the other of caraway.

The harsh example is thalidomide. In the early 1960s, the sedative caused birth defects in thousands of children, and the committee notes that later analysis pinned the harm on the drug's mirror image. "The left-handed version of the drug can have one effect, and the right-handed version can have another effect," committee member Peter Somfai told reporters.

So drug chemists want reactions that make only the useful hand. Asking which medicines use this year's discoveries, Somfai said: "I would say all of them, because we use this as a tool." Rigoberto Hernandez, president of the American Chemical Society, said: "The medicines we have today would not be possible without this chemistry."

Kagan breaks the straight line

By the early 1980s, chemists drove asymmetric reactions with two-part catalysts: a metal atom doing the work and a chiral molecule steering it. The working assumption was linear. If the steering molecule was 50% pure, the product would come out about 50% pure. Purity in, purity out.

Kagan questioned that. Metal atoms usually grab more than one partner, he reasoned, so the catalyst might carry two chiral molecules at once. Mix left and right forms and you get three catalysts: left-left, right-right, and a mixed left-right. In 1986, in the Journal of the American Chemical Society, he reported three reactions where the result curved away from the straight line. The mixed catalyst ran far more slowly than the matched ones, so it effectively removed itself from the game, and the product came out more lopsided than the catalyst that made it.

That curve, the non-linear effect, became a standard diagnostic. The committee's background says it tells chemists how a reaction actually works, which is how they tune it toward the purest product, whether they are making medicines, flavours, scents or farm chemicals.

Soai's reaction copies itself

Soai, studying a reaction with a strong non-linear effect, saw that its product looked a lot like its catalyst. Could the product make more of itself?

After much trial and error he found a molecule that could: 5-pyrimidyl alkanol. In a 1995 paper, he started with a 2% excess of one enantiomer and ended with 87%. The product catalysed its own formation and favoured its own hand, which was exactly the self-reinforcing loop the physicist Charles Frank had sketched on paper in 1953 as a possible route to life's homochirality.

Then he went further. In 2003, Soai showed a version that began with no chiral bias at all. Both hands formed at first, chance gave one a slight edge, and that edge took over. According to the committee, the winner can reach 99.99% of the product. Run it again and the other hand might win. In the committee's words, other than life itself, no one had previously achieved this feat. Somfai went further at the announcement: "This is probably the coolest experiment in organic chemistry."

What it says, and doesn't say, about life

It is tempting to say Soai solved the origin of life. The committee is careful not to. The Soai reaction is artificial, and its chemistry is nothing like the chemistry of amino acids or sugars. What it proves is the principle: a random flicker of asymmetry, fed into an autocatalytic loop, can lock a whole system into one hand without help from biology.

That changes the question. It is no longer whether chemistry can break the mirror by itself, because Soai showed it can. It is whether the actual building blocks of life can do it under conditions the early Earth could have offered. The committee says labs around the world are now trying to get the same result with amino acids and sugars. Soai sounded the same note at a Tokyo news conference: "There are still fascinating aspects that remain unknown and surely more yet to be discovered."

Why the pairing works

Kagan, born in 1930, is 95. Soai, born in 1950, is 76 and heard the news while shopping near his home. They will share 12 million Swedish kronor. Their work fits together like links in a chain. Kagan showed a catalyst's handedness can be amplified rather than merely copied. Soai built a reaction where amplification feeds on itself until one hand wins.

For chemistry, that means a sharper toolkit for making the right molecule and knowing why it worked. For the bigger question, it is the first convincing lab demonstration of something only life had managed: choosing a side, and keeping it.